0000899243-20-023369.txt : 20200825 0000899243-20-023369.hdr.sgml : 20200825 20200825163050 ACCESSION NUMBER: 0000899243-20-023369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200825 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Steven Edward CENTRAL INDEX KEY: 0001602732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 201132618 MAIL ADDRESS: STREET 1: 15001 BARNHARDT CT CITY: CHAPEL HILL STATE: NC ZIP: 27517 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-25 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001602732 Hall Steven Edward C/O LILLY VENTURES 333 N. ALABAMA ST., SUITE 350 INDIANAPOLIS IN 46204 1 0 0 0 Common Stock 2020-08-25 4 C 0 2192249 A 2192249 I See Footnote Series A Convertible Preferred Stock 2020-08-25 4 C 0 2511198 0.00 D Common Stock 1574517 0 I See Footnote Series B Convertible Preferred Stock 2020-08-25 4 C 0 985220 0.00 D Common Stock 617732 0 I See Footnote Represents the total number of shares of common stock received upon the conversion of the Issuer's preferred stock in connection with the closing of the Issuer's initial public offering. All series of preferred stock automatically converted into the Issuer's common stock on a one-for-1.5949 basis upon the closing of the Issuer's initial public offering and had no expiration date. These shares are held directly by Lilly Ventures Fund I, LLC (LVFI). LV Management Group, LLC (LVMG) is the management company for LVFI and has voting and dispositive power over the shares held by LVFI. As such, LVMG may be deemed to indirectly beneficially own the shares held by LVFI. LVMG's voting and dispositive decisions with respect to the shares held by LVFI are made by LVMG's management committee, which includes the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. /s/ Bruce N. Jacobs, as Attorney-in-Fact 2020-08-25